Seroepidemiology of hbv infection in south-east of Iran; a population based study

Iranian Red Crescent Medical Journal

Volumn 14, Issue 5, 2012, Pages 283-288

  Salehi, M ^a   Alavian, S M ^b   Tabatabaei, S V ^c   Izadi, Sh ^d   Sanei Moghaddam, E ^e   Amini Kafi Abad, S ^e   Gharehbaghian, A ^e   Khosravi, S ^e   Abolghasemi, H ^e  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Epidemiology; HBV; Hepatitis; Iran

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SCREENING TEST; SEROEPIDEMIOLOGY;

EID: 84861160894     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore 1980;9:144-148. [7425524]
2. Alavian SM, Fallahian F, Lankarani KB. The Changing Epidemiology of Viral Hepatitis B in Iran. J Gastrointestin Liver Dis 2007;16: 403-406. [18193122]
3. Bagheri Lankarani K, Saberi Froozi M, Nabipoor I, Fattahi F, Sarafrazyazdi M, Malekzadeh R. Reassesment of the role of hepatitis B and C viruses in southern Iran. Iran J Med Sci 1999;24:117-121.
4. Shamszad M, Farzadegan H. Related cirrhosis and hepatocellular carcinoma in Iran. J Iran Med Council 1982;8:228.
5. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. J Iran Med Council 1997;15: 183-200.
6. Rizetto M, Purcell RH, Gerin JL, Verme G. Control of hepatitis B in the Middle East. In: Toukan AU, editor. Viral Hepat liver Dis 1st ed. Turin: Minerva Media; 1997. pp. 678-680.
7. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993;96:277-287. [8411302]
8. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000;6:1114-1116. [12197336]
9. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000;2:192-201. [19400598]
10. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, Adibi P, Sadri GH, Keramat F, Ardalan A, Arabi M, Gharekhani S, Ataei A, Amraei GR, Hosseinzadeh M, Hatami S, Zali M. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J 2006;12:528-537. [17333790]
11. Khedmat H, Alavian SM, Miri SM, Amini M, Abolghasemi H, Hajibeigi B, Alaeddini F, Fallahian F. Trends in Seroprevalence of Hepatitis B, Hepatitis C, HIV, and Syphilis Infections in Iranian Blood Donors from 2003 to 2005. Hepat Mon 2009;9:24-28.
12. Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, Adibi P. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study. Hepat Mon 2009;9:12-16.
13. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin, IR.Iran. Hepat Mon 2005;5:117-122.
14. Alavian SM. Hepatitis B virus infection in Iran; Changing the epidemiology. Iran J Clin Infect Dis 2010;5:51-61.
15. Alavian SM, Hajariazdeh B, Ahmadzad Asl M, Kabir A, Bagheri Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon 2008;8:281-294.
16. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepat Mon 2011;11:19-22. [22087111]
17. Sali SH, Bashtar R, Alavian SM. Risk Factors in Chronic Hepatitis B Infection: A Case-control Study. Hepat Mon 2005;5:109-115.
18. Alavian SM, Fallahian F, Lankarani KB. Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan. Hepat Mon 2007;7:233-238.
19. Hollinger FB, Habibollahi P, Daneshmand A, Alavian SM. Occult Hepatitis B Infection in Chronic Hemodialysis Patients: Current Concepts and Strategy. Hepat Mon 2010;10:199-204.
20. Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D. Seroprevalence of Hepatitis B virus among hemodialysis patients in Bushehr Province, Southern Iran. Hepat Mon 2011;11:200-202.
21. Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M, Salman F, Aydogan F. Risk Factors for Hepatitis B Virus Infection in Turkey: A Population-Based, Case-Control Study. Hepat Mon 2011;11:263-268. [22087152]
22. Hajiani E, Hashemi S, Masjedizadeh A. Seroepidemiology of Hepatitis B Virus Infection in Khuzestan Province, Southwest of Iran. Hepat Mon 2009;9:34-38.
23. Salkic NN. Intrafamilial Transmission of Hepatitis B: Experience and Lessons Learned in Bosnia and Herzegovina. Hepat Mon 2009; 9:169-170.
24. Asli AA, Moghadami M, Zamiri N, Tolide-Ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against hepatitis B among prisoners in Iran: Accelerated vs. classic vaccination. Health Policy 2011; 100:297-304. [21269722] [doi.org/ 10.1016/j.healthpol.2010.12.007]